BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 14518336)

  • 21. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.
    Muppidi JR; Siegel RM
    Nat Immunol; 2004 Feb; 5(2):182-9. PubMed ID: 14745445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The response of human T lymphocytes against alloantigens following Fas-mediated activation-induced cell death.
    Fujiwara T; Fujita H; Muranaka S; Utsumi K; Kusaka S; Hamazaki K
    Transplant Proc; 2005; 37(1):46-8. PubMed ID: 15808542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of murine hepatocyte death by membrane-bound CD95 (Fas/APO-1)-ligand: characterization of an in vitro system.
    Schlosser SF; Azzaroli F; Dao T; Hingorani R; Crispe IN; Boyer JL
    Hepatology; 2000 Oct; 32(4 Pt 1):779-85. PubMed ID: 11003622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autocrine activation-induced cell death of T cells by human peripheral blood monocyte-derived CD4+ dendritic cells.
    Sato K; Nagayama H; Enomoto M; Tadokoro K; Juji T; Takahashi TA
    Cell Immunol; 2000 Feb; 199(2):115-25. PubMed ID: 10698621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation-induced cell death in T cells and autoimmunity.
    Zhang J; Xu X; Liu Y
    Cell Mol Immunol; 2004 Jun; 1(3):186-92. PubMed ID: 16219166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociation of T cell anergy from apoptosis by blockade of Fas/Apo-1 (CD95) signaling.
    Hargreaves RG; Borthwick NJ; Gilardini Montani MS; Piccolella E; Carmichael P; Lechler RI; Akbar AN; Lombardi G
    J Immunol; 1997 Apr; 158(7):3099-107. PubMed ID: 9120262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD95L mediates tumor counterattack in vitro but induces neutrophil-independent tumor rejection in vivo.
    Igney FH; Behrens CK; Krammer PH
    Int J Cancer; 2005 Jan; 113(1):78-87. PubMed ID: 15386427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.
    Inaba M; Kurasawa K; Mamura M; Kumano K; Saito Y; Iwamoto I
    J Immunol; 1999 Aug; 163(3):1315-20. PubMed ID: 10415029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system.
    Schwarz A; Grabbe S; Grosse-Heitmeyer K; Roters B; Riemann H; Luger TA; Trinchieri G; Schwarz T
    J Immunol; 1998 May; 160(9):4262-70. PubMed ID: 9574528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
    Oberg HH; Lengl-Janssen B; Kabelitz D; Janssen O
    Cell Immunol; 1997 Oct; 181(1):93-100. PubMed ID: 9344501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells.
    McDaid J; Yamashita K; Chora A; Ollinger R; Strom TB; Li XC; Bach FH; Soares MP
    FASEB J; 2005 Mar; 19(3):458-60. PubMed ID: 15640283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of apoptosis by IFNgamma in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit.
    Bernassola F; Scheuerpflug C; Herr I; Krammer PH; Debatin KM; Melino G
    Cell Death Differ; 1999 Jul; 6(7):652-60. PubMed ID: 10453076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta 1 derived from biliary epithelial cells may attenuate alloantigen-specific immune responses.
    Narumoto K; Saibara T; Maeda T; Onishi S; Hayashi Y; Miyazaki E; Hiroi M; Enzan H; Kobayashi N
    Transpl Int; 2000; 13(1):21-7. PubMed ID: 10743685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allopeptide-mediated expression of endothelial Fas-ligand (CD95L) in long-term tolerized heterotopic rat heart grafts.
    Fändrich F; Dresske B; Lin X; Huang DS; Zavazava N; Henne-Bruns D
    Transplant Proc; 1999 May; 31(3):1558-9. PubMed ID: 10330999
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunobiology of renal transplantation.
    Valente JF; Alexander JW
    Surg Clin North Am; 1998 Feb; 78(1):1-26. PubMed ID: 9531932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunologic disorders in pathogenesis of chronic generalized parodontitis].
    Volozhin AI; Poriadin GV; Kazimiski TI; Barer GM; Askerova SSh; Salmasi ZhM
    Stomatologiia (Mosk); 2005; 84(3):4-7. PubMed ID: 16007004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunology. Ways around rejection.
    Vaux DL
    Nature; 1995 Oct; 377(6550):576-7. PubMed ID: 7566165
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased Fas ligand expression and activated T-lymphocyte apoptosis in islet graft tolerance induced by liver transplantation.
    Sun J; Wang X; Wang C; France M; Sheil A
    Transplant Proc; 2001; 33(1-2):227-8. PubMed ID: 11266791
    [No Abstract]   [Full Text] [Related]  

  • 39. Apoptosis and transplantation tolerance.
    Chiffoleau E; Walsh PT; Turka L
    Immunol Rev; 2003 Jun; 193():124-45. PubMed ID: 12752677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characterization of spontaneous transplant tolerance exemplified by orthotopic liver transplantation: significance of Fas ligand induced programmed cell death].
    Fändrich F; Lin X; Klöppel G; Kremer B
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):361-5. PubMed ID: 14518276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.